Special Phage Holdings wins NSW commercialisation award

Crunching the numbers from multivariate statistics sounds a rather dry topic to wet lab specialists, but a group of CSIRO researchers has taken a rather philosophical approach to managing the data mountain.

Cell therapy company CyGenics (ASX:CYN) has taken a 51 per cent controlling equity interest in cord blood stem cell banking business BioCell.

A new report on ASX-listed life sciences companies by PricewaterhouseCoopers shows that the sector has posted its worst quarterly performance in three years.

Pfizer Australia has hired cryogenic storage company Cryosite (ASX:CTE) to handle storage of its clinical trial drugs in Australia, and Cryosite CEO Gordon Milliken has pointed to a growing trend for big pharma and international biotechs to outsource the storage and logistics of their newest drugs to local service providers.

Multinational pharma Bristol-Myers Squibb has engaged Sydney-based cryogenic-storage company Cryosite (ASX:CTE) to manage its clinical trial supply logistics in Australia and New Zealand.

Sydney-based cryogenic storage company Cryosite (ASX: CTE) has entered into an agreement with Melbourne's Peter MacCallum Cancer Centre to provide long term storage of patients' blood stem cells.